07 Nov Biomedical Entrepreneurship and its Unique Challenges
Biomedical Innovation Fireside Chats
Session 1: Biomedical Entrepreneurship and its Unique Challenges
Join regional program leaders for virtual “fireside chats” with biomedical entrepreneurs, investors, and industry experts. Panel discussions are aimed at early-stage academic innovators who need to quickly learn the essentials. Events will be held over Zoom and recorded. Learn more about the series and the rest of the sessions here.
Topics of discussion for this first session will include:
- Clinical Need
- Workflow Integration
- Patient vs Purchaser
- Safety & Efficacy
About the Host
Terri Butler, PhD, works with faculty and students at the University of Washington and collaborating Pacific Northwest research institutions advising on commercialization pathways for biomedical technologies. She is the primary contact for the ITHS Drug and Device Advisory Committee and manages the WE-REACH Biomedical Innovation Bootcamp. Dr. Butler draws on her industry experience to assist teams in vetting their ideas through a rigorous process of competitor analysis and market validation as well as laying out strategies for technical development. Prior to coming to the University, Dr. Butler worked in key industry roles along the commercialization pathway, including invention, product development, FDA regulatory management, manufacturing scale-up, and sales and marketing. She has worked at large and small companies, including 3M, Molecular Genetics, Bioenergy Life Sciences, and multiple university spin-out companies. Products she has commercialized include monoclonal antibodies, pharmaceutical release liner, nutritional formulations, and non-medical technologies in the high-tech materials field. She is an inventor on 14 patents in coating processes, chemical formulations, and nutritional applications.